What’s Going on with the Advertising Standards Authority?

Don’t get me wrong, I have enormous respect for the ASA. Above all else, they are seriously annoying the quacks and charlatans, notably “What Doctors Don’t Tell You“, the magazine that makes up silly stories about health, disease, and treatments. But I am wondering whether the ASA is falling victim to the IT-driven tick-box mentality that pervades modern society and business. Continue reading

The Myth of Big Pharma

Forty years ago this year (god, can it be so long?), I joined the pharmaceutical industry. Its reputation then was little better then than it is now, various companies having weathered scandals in the previous two decades. In the 1950s Pfizer was top UK company by a long way, on the back of its tetracycline antibiotics. Oxytetracycline was promoted via golf weekends for doctors, and a dimpled ball emblazoned with the brand name Terramycin was famously brandished in the House of Commons in the late 1960s by Gwyneth Dunwoody MP. Not many years later I was working for Pfizer, and doctors still asked me for golf balls, I suspect only half in jest. In the 1960s Roche was forced to repay excessive profits from benzodiazepine anxiolytics, and of course the now long gone Distillers Company presided over the worst ever case of teratogenic damage from a drug. Continue reading

More Cherry-Picked `Evidence’

Some of you will have seen an email that went out the other day to subscribers to the `What Doctors Don’t Tell You’ website. Here it is:

Would you like to be featured in a future issue of What Doctors Don’t Tell You (WDDTY) magazine? Continue reading

The Burzynski Soap Opera

Burzynski’s Export Drive

The saga of Dr Stanislaw Burzynski and his antineoplastons (ANPs) is in danger of turning into a soap opera. Well actually it probably already has, as it has gone on for decades with no real plot and no end in sight. Many bloggers have been as puzzled as I as to why the US regulator, the FDA, allows this to continue. Admittedly, from time to time the FDA takes some sort of action, but it is never decisive – he is always allowed to carry on charging desperate patients vast sums to receive an unproven drug. Continue reading

Is the FDA Protecting Burzynski?

And if so, why? Last night is had a phone call with Elisabeth Lee, Regulatory Counsel, Division of Information Disclosure Policy at the Center for Drug Evaluation and Research. Continue reading

Charity begins……where?

I’m not sure where it begins, but I’m more than a little concerned at where it seems to be going. I’m sure you all know about the deeply embarrassing (for its patron) closure of the Prince’s Foundation for Integrated Health, a charity which openly campaigned for alternative medical `treatments’ (charities are not supposed to campaign). At the time I wondered why the Charity Commission didn’t investigate it a long time before the debacle, as `significant financial loss’ is a cause for investigation. Continue reading

Now we know how Burzynski gets away with it

Further to my questions put to Dr Constance Lewin at the FDA, I was greatly cheered to receive a reply on 12th December. Well of course I didn’t get the honour of a reply from the august Dr Lewin herself, but from Karen Mahoney, of Trade Media at the Center for Drug Evaluation and Research. Continue reading

%d bloggers like this: